Steven Kanner
Hoofd Techniek/Wetenschap/O&O bij CARIBOU BIOSCIENCES, INC.
Vermogen: 1 M $ op 30-04-2024
Actieve functies van Steven Kanner
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CARIBOU BIOSCIENCES, INC. | Hoofd Techniek/Wetenschap/O&O | 01-06-2017 | - |
Specific Biologics, Inc.
 Specific Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Specific Biologics, Inc. is a biotechnology company that focuses on developing gene editing technologies to treat diseases through precision gene editing. The company is based in Toronto, Canada. The Canadian company's two-site dualase™ platform gene editors cut DNA in a way that optimally exploits the cells naturally occurring DNA repair pathways, enabling two gene editing outcomes, precise DNA deletions to disrupt genes or increased repair to correct genes. Specific also develops lipid nanoparticles to deliver the gene editor to target cells and is developing a pipeline of dualase™-based therapeutics in areas of high unmet medical need. The company was founded in 2017. The CEO is Brent Stead. | Directeur/Bestuurslid | 10-10-2023 | - |
| Independent Dir/Board Member | 10-10-2023 | - |
Loopbaan van Steven Kanner
Eerdere bekende functies van Steven Kanner
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 19-09-2013 | 01-06-2017 |
Opleiding van Steven Kanner
| University of California, Berkeley | Undergraduate Degree |
| The University of Miami Leonard M. Miller School of Medicine | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| Canada | 2 |
Operationeel
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Health Technology |
| CARIBOU BIOSCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Specific Biologics, Inc.
Specific Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Specific Biologics, Inc. is a biotechnology company that focuses on developing gene editing technologies to treat diseases through precision gene editing. The company is based in Toronto, Canada. The Canadian company's two-site dualase™ platform gene editors cut DNA in a way that optimally exploits the cells naturally occurring DNA repair pathways, enabling two gene editing outcomes, precise DNA deletions to disrupt genes or increased repair to correct genes. Specific also develops lipid nanoparticles to deliver the gene editor to target cells and is developing a pipeline of dualase™-based therapeutics in areas of high unmet medical need. The company was founded in 2017. The CEO is Brent Stead. | Commercial Services |
- Beurs
- Insiders
- Steven Kanner
- Ervaring
